NewLink Genetics to Participate in the Jefferies 2018 Global Healthcare Conference

AMES, Iowa, May 30, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK) announced today that the company will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018, at 8:00AM ET. 

A live webcast of the presentation will be available on the Company’s website at www.newlinkgenetics.com in the “Investors & Media” section under “Events and Presentations.”  An archived edition of the presentation will be available on the Company’s website later in the day. 

About NewLink Genetics Corporation

NewLink Genetics is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics' leading drug candidate, indoximod, is an investigational, orally available small molecule designed to harness multiple components of the immune system to combat cancer. For more information, please visit www.newlinkgenetics.com and follow us on Twitter @NLNKGenetics.

Investor Contact:

Lisa Miller
Director of Investor Relations
NewLink Genetics
515-598-2555
[email protected]

Media Contact:

Sharon Correia
VP, Integrated Communications
LaVoieHealthScience
617-374-8800, ext. 105
[email protected]

You May Also Be Interested In

• Géopolitique Profonde (GPTV) Surpasses 800,000 YouTube Subscribers, Confirming Its Standing as France's Leading Independent Media Outlet on Wealth Protection
• Noveris Health Sciences Receives USPTO Notice of Allowance, and Signs Work Order with API
• Impact Podcast with John Shegerian Features Rising Stars of ITAD in Special Episode Taped Live at ITAD Summit 2026